Naltrexone Therapy for Crohn's Disease and Ulcerative Colitis

被引：0
作者：
Weinstock, Leonard B. [1 ,2 ]
机构：
[1] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA
[2] Specialists Gastroenterol LLC, St Louis, MO USA
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 2014年 / 48卷 / 08期
关键词：
LOW-DOSE NALTREXONE; INFLAMMATORY-BOWEL-DISEASE;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：742 / 742
页数：1
相关论文
共 50 条
  • [41] Carbohydrate Intake in the Etiology of Crohn's Disease and Ulcerative Colitis
    Chan, Simon S. M.
    Luben, Robert
    van Schaik, Fiona
    Oldenburg, Bas
    Bueno-De-Mesquita, H. Bas
    Hallmans, Goran
    Karling, Pontus
    Lindgren, Stefan
    Grip, Olof
    Key, Timothy
    Crowe, Francesca L.
    Bergmann, Manuela M.
    Overvad, Kim
    Palli, Domenico
    Masala, Giovanna
    Khaw, Kay-Tee
    Racine, Antoine
    Carbonnel, Franck
    Boutron-Ruault, Marie-Christine
    Olsen, Anja
    Tjonneland, Anne
    Kaaks, Rudolf
    Tumino, Rosario
    Trichopoulou, Antonia
    Hart, Andrew R.
    INFLAMMATORY BOWEL DISEASES, 2014, 20 (11) : 2013 - 2021
  • [42] MUCOSAL FLORA IN CROHN'S DISEASE AND ULCERATIVE COLITIS - AN OVERVIEW
    Swidsinski, A.
    Loening-Baucke, V.
    Herber, A.
    JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2009, 60 : 61 - 71
  • [43] Evaluation of inflammatory activity in Crohn's disease and ulcerative colitis
    Eduardo Garcia Vilela
    Henrique Osvaldo da Gama Torres
    Fabiana Paiva Martins
    Maria de Lourdes de Abreu Ferrari
    Marcella Menezes Andrade
    Aloísio Sales da Cunha
    World Journal of Gastroenterology, 2012, 18 (09) : 872 - 881
  • [44] Diagnosis of Crohn’s disease and ulcerative colitis using the microbiome
    Da-Yeon Kang
    Jong-Lyul Park
    Min-Kyung Yeo
    Sang-Bum Kang
    Jin-Man Kim
    Ju Seok Kim
    Seon-Young Kim
    BMC Microbiology, 23
  • [45] Optimizing Biologic Agents in Ulcerative Colitis and Crohn’s Disease
    O’Toole A.
    Moss A.C.
    Current Gastroenterology Reports, 2015, 17 (8)
  • [46] Crohn's disease and ulcerative colitis - current view on genetic determination, immunopathogenesis and biologic therapy
    Buc, M.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2017, 66 (04): : 189 - 197
  • [47] Adalimumab biosimilars in the therapy of Crohn′s disease and ulcerative colitis: Prospective multicentric clinical monitoring
    Wasserbauer, Martin
    Hlava, Stepan
    Drabek, Jiri
    Stovicek, Jan
    Minarikova, Petra
    Nedbalova, Lenka
    Drasar, Tomas
    Zadorova, Zdena
    Dolina, Jiri
    Konecny, Stefan
    Kojecky, Vladimir
    Kozeluhova, Jana
    Cernikova, Pavlina
    Pichlerova, Dita
    Kucerova, Barbora
    Coufal, Stepan
    Keil, Radan
    PLOS ONE, 2022, 17 (08):
  • [48] Treatment Pathways in Patients With Crohn's Disease and Ulcerative Colitis: Understanding the Road to Advanced Therapy
    Siegel, Corey A.
    Sharma, Dolly
    Griffith, Jenny
    Doan, Quynhchau
    Xuan, Si
    Malter, Lisa
    CROHNS & COLITIS 360, 2024, 6 (03)
  • [49] Neopterin Concentration as an Index of Disease Activity in Crohn's Disease and Ulcerative Colitis
    Husain, Nisreen
    Tokoro, Ken
    Popov, Joanna M.
    Naides, Stanley J.
    Kwasny, Mary J.
    Buchman, Alan L.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2013, 47 (03) : 246 - 251
  • [50] A new model for the discrimination between ulcerative colitis and Crohn's disease
    Shen, Zhe
    Ma, Wei-Ping
    Shao, Xiao-Na
    Yu, Chao-Hui
    Du, Juan
    Xiang, Zun
    Guo, Gan-Hua
    Zhang, Hong
    Li, You-Ming
    Yue, Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (01): : 854 - 861
12345